D48.116
Desmoid tumor of lower extremity and pelvic girdle
Clinical Classification Guidelines
Inclusion Terms
- Desmoid tumor of buttock
Medical Intelligence & Overview
A desmoid tumor, also known as aggressive fibromatosis, is a rare type of benign growth that develops from fibroblastic cells. While non-cancerous, desmoid tumors can be locally invasive, causing significant tissue destruction and complications. When occurring in the lower extremity and pelvic girdle, including areas like the buttock, these tumors can present unique challenges due to their location. Despite their benign classification, desmoid tumors can be aggressive in their growth behavior, requiring careful management.
Causes & Symptoms
Clinical Causes: Genetic factors: Certain inherited conditions, such as familial adenomatous polyposis (FAP), particularly Gardner's syndrome, increase the risk. Hormonal influences: Elevated levels of estrogen may play a role, which can explain the higher occurrence in women, particularly during pregnancy or hormone therapy. Trauma or injury: Previous surgical procedures, injuries, or repetitive trauma in the affected area can sometimes trigger tumor development. Unknown factors: In many cases, the exact cause remains unidentified, highlighting the complex and uncertain nature of this tumor's origin.
Key Symptoms: A noticeable lump or swelling in the thigh, buttock, or pelvic region. Pain or tenderness around the tumor site, especially as the tumor enlarges. Limited mobility or discomfort during movement due to the tumor's invasive growth. Firm, deep-seated mass that may be fixed to surrounding tissues or structures. In some cases, the tumor’s growth can compress nearby nerves or blood vessels, leading to additional symptoms.
Diagnostic & Treatment
Diagnosis Path: Diagnosing a desmoid tumor involves multiple steps to accurately identify and assess the growth. Imaging techniques such as magnetic resonance imaging (MRI) are commonly used to determine the size, extent, and relation to surrounding tissues. A biopsy, which involves taking a tissue sample from the tumor, confirms the diagnosis by identifying characteristic fibrous tissue. Additional tests, like detailed medical history and physical examination, support the diagnosis and help in planning treatment strategies.
Treatment Protocols: Treatment options for desmoid tumors are tailored based on the tumor's size, location, growth rate, and impact on surrounding tissues. Approaches include: - Surgical excision: Removing the tumor with clear margins to minimize the chance of recurrence. Complete removal can be challenging if the tumor involves vital structures. - Observation: In some cases, particularly if the tumor is small, slow-growing, or asymptomatic, active monitoring may be recommended. - Medical therapies: Including hormone therapy, nonsteroidal anti-inflammatory drugs (NSAIDs), or targeted agents that can shrink or slow tumor growth. - Radiation therapy: Used in cases where surgery is not feasible or as an adjunct to reduce recurrence risk. Multidisciplinary management, involving surgeons, oncologists, and radiologists, ensures a comprehensive approach to treatment and follow-up care.
Clinical Advice & FAQs
Billing Guidance
Is D48.116 a billable ICD-10 code?
Yes, D48.116 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report D48.116?
Clinical documentation must specify the nature of Desmoid tumor of lower extremity and pelvic girdle and any associated comorbidities for accurate reporting.
Cite this Clinical Reference